JCC Plus
Cure8 research brief
Why This Matters
This study highlights changing patterns of IBD presentation and treatment over 26 years in a large Hispanic cohort, which may affect outcomes and access-to-care discussions for Hispanic patients.
Rising use of biologic therapies and differences in disease behavior could inform clinical expectations and research about ethnic disparities.
Who Should Pay Attention
Hispanic adults with IBD or families; clinicians treating Hispanic patients with IBD; researchers studying IBD epidemiology, health disparities, and treatment trends.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This abstract reports registry findings from the University of Puerto Rico IBD Registry (1995–2020) describing demographic and clinical trends among 1,365 Hispanic patients with IBD.
The authors compare two time periods and report shifts in diagnosis proportions, medication use (notably large increases in anti‑TNF and immunomodulator use and declines in aminosalicylates/steroids), changes in Crohn's disease behavior and extent, stable surgery rates, and changes in extraintestinal manifestations and family history.
Keep In Mind
The paper is an observational registry analysis spanning 1995–2020. Temporal trends may reflect changes in diagnostics, healthcare access, physician awareness, population aging, and migration; registry data describe associations and cannot establish causation.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationJCC Plus
AuthorsAlondra Soto-González, Lizzie Ramos-Tollinchi, Claudia Amaya +6 more
InstitutionUniversity of Puerto Rico System
Study typeArticle
Indexed viaOpenAlex
Source typeResearch paper
PublishedAug 14, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
SURGICAL APPROACH, BIOLOGICAL THERAPIES, AND INFLAMMATORY MECHANISMS ASSOCIATED WITH ULCERATIVE COLITIS AND CROHN'S DISEASE
The review links specific therapies and surgical options to outcomes that matter to people with IBD — mucosal healing, lower hospitalizations, and reduced need for surgery — and highlights that combining medical and...
Large Vessel Vasculitis in IBD Linked to Younger Onset, Distinct Clinical Features
This study suggests LVV can occur in people with IBD at younger ages and with distinct vascular findings, and it may arise even when gut disease is in remission. That matters for awareness, diagnosis, and coordination...
A Real-World Study of Upadacitinib in Anti-TNF Refractory Crohn's Disease - Dove Medical Press
This study looks at upadacitinib in people with Crohn’s disease who did not respond to anti-TNF drugs — a common and challenging clinical situation.